Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma
Rolando Pérez‐Lorenzo(Autonomous University of Campeche), Raphael Clynes(Xencor (United States))
Cited by 5
Related Papers
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
|JCI Insight|2016|286
Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis
|Carcinogenesis|2010|18